Skip to content

Programmalith Ii, #225 & 226

by Pacesetter Systems 510(k)

Active United States

510(k) K821003

Overview

The Programmalith II, Models 225 & 226, is an implantable pacemaker pulse-generator designed to regulate cardiac rhythm in patients with bradycardia or conduction system disorders. This device delivers electrical impulses to stimulate the heart muscle, ensuring consistent and appropriate heart contractions when the natural pacemaker fails.

These pulse-generators are intended for surgical implantation and are classified as Class III medical devices under FDA regulations. Supplied sterile and intended for single-use, they require proper handling and storage as per manufacturer guidelines. The devices are authorized under FDA 510(k) clearance (K821003) and fall under the regulation number 870.3610, adhering to strict cardiovascular device standards.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK821003 Date7 May 1982ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Pacesetter Systems

See all devices from Pacesetter Systems →

Questions

  • What is the primary clinical purpose of the Programmalith II, Models 225 & 226, and which patient conditions does it address?

    The Programmalith II, Models 225 & 226, is designed to regulate cardiac rhythm by delivering electrical impulses to stimulate the heart muscle. It is specifically intended for patients with bradycardia (slow heart rate) or conduction system disorders where the heart’s natural pacemaker is not functioning properly.

  • Are these devices meant for single-use or can they be reused after implantation?

    The Programmalith II, Models 225 & 226, are supplied sterile and explicitly intended for single-use only. Reuse is not recommended or supported by the manufacturer, as this could compromise sterility and patient safety.

  • How should these devices be stored to maintain their integrity before use?

    Since these pulse-generators are sterile and single-use, they must be stored according to the manufacturer’s guidelines to preserve sterility. This typically includes keeping them in their original packaging, in a clean, dry environment, and away from extreme temperatures or direct sunlight until implantation.

  • What regulatory pathway was followed for FDA clearance of the Programmalith II, and which committee reviewed it?

    The Programmalith II, Models 225 & 226, received FDA clearance through a Traditional 510(k) pathway (K821003) and was reviewed by the Cardiovascular (CV) Advisory Committee. The device is classified as a Class III medical device under FDA regulations, adhering to the specific standards outlined in regulation number 870.3610.